NEW YORK–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/clinicaltrials?src=hash” target=”_blank”gt;#clinicaltrialslt;/agt;–Medidata
(NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial
officer, will present at the Jefferies 2019 Healthcare Conference on
Thursday, June 6, 2019, at 9 a.m. ET in New York.
A live audio webcast and replay of each presentation will be available
at https://investors.medidata.com.
About Medidata:
Medidata is leading the digital transformation of life sciences, with
the world’s most-used platform for clinical development, commercial, and
real-world data. Powered by artificial intelligence and delivered by top
ranked industry experts, Medidata helps pharmaceutical, biotech, medical
device companies, and academic researchers accelerate value, minimize
risk and optimize outcomes. Medidata and its companies, Acorn AI and
SHYFT, serve more than 1,200 customers and partners worldwide and
empower more than 150,000 certified users every day to create hope for
millions of patients. Discover the future of life sciences: www.medidata.com
Contacts
Investors:
Betsy Frank, 917-522-4620
[email protected]
or
Media:
Erik
Snider, 646-362-2997
[email protected]
